Bone Marrow Mesenchymal Stem Cells: From Characterization of Neural Differentiation to a Possible Therapeutic Use in Neurodegeneration
Identifieur interne : 001619 ( Istex/Corpus ); précédent : 001618; suivant : 001620Bone Marrow Mesenchymal Stem Cells: From Characterization of Neural Differentiation to a Possible Therapeutic Use in Neurodegeneration
Auteurs : S. Arnhold ; H. Klein ; L. Benmime ; K. AddicksSource :
- Anatomia, Histologia, Embryologia [ 0340-2096 ] ; 2005-12.
Abstract
Bone marrow derived stromal cells are of mesenchymal origin and precursor cells for skeletal tissue components such as chondroblasts and osteoblasts. Furthermore, under experimental conditions, a differentiation potency into myogenic and neuronal cells could be demonstrated. Because of their multipotency these cells represent a population of non‐haematogen stem cells that can be regarded as an alternative to human embryonic stem cells for future autologous cell replacement therapies. For a closer look at the differentiation capacity of these cells, rat and human bone marrow stromal cells were isolated from the femur bone and kept in the cell culture applying different cultivation protocols. In a cultivation medium with a serum content of 20%, the majority of these cells express a variety of neuronal markers such as ß‐III Tubulin and NeuN as well as the astrocyte marker GFAP, while a minority of about 20% express the marker for neural precursor cells nestin. Cultivation in a chemically defined serum free medium results in the differentiation of a markedly higher percentage of nestin positive neural precursor‐like cells. Using bFGF in combination with B27 these cells can be forced to form three dimensionally organized spheres. In order to elucidate a possible therapeutical potency of the bone marrow derived cells the synthesis of neurotrophic factors such as BDNF and NGF were analysed using the ELISA technique. Furthermore, they can be infected using a third generation adenoviral vector with high efficiency and show migratory activity in vitro. After injection of bone marrow derived mesenchymal stem cells into the lateral ventricle of adult rats they adhere to the ependymocytes and pass the ependymal barrier in order to settle in the subventricular space.
Url:
DOI: 10.1111/j.1439-0264.2005.00669_10.x
Links to Exploration step
ISTEX:9FA51D35AF5B7CF622B27D12E76A80A775E80781Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Bone Marrow Mesenchymal Stem Cells: From Characterization of Neural Differentiation to a Possible Therapeutic Use in Neurodegeneration</title><author><name sortKey="Arnhold, S" sort="Arnhold, S" uniqKey="Arnhold S" first="S." last="Arnhold">S. Arnhold</name><affiliation><mods:affiliation>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</mods:affiliation></affiliation></author><author><name sortKey="Klein, H" sort="Klein, H" uniqKey="Klein H" first="H." last="Klein">H. Klein</name><affiliation><mods:affiliation>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</mods:affiliation></affiliation></author><author><name sortKey="Benmime, L" sort="Benmime, L" uniqKey="Benmime L" first="L." last="Benmime">L. Benmime</name><affiliation><mods:affiliation>Clinic for Cardiosurgery, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</mods:affiliation></affiliation></author><author><name sortKey="Addicks, K" sort="Addicks, K" uniqKey="Addicks K" first="K." last="Addicks">K. Addicks</name><affiliation><mods:affiliation>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:9FA51D35AF5B7CF622B27D12E76A80A775E80781</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1111/j.1439-0264.2005.00669_10.x</idno><idno type="url">https://api.istex.fr/document/9FA51D35AF5B7CF622B27D12E76A80A775E80781/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001619</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001619</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Bone Marrow Mesenchymal Stem Cells: From Characterization of Neural Differentiation to a Possible Therapeutic Use in Neurodegeneration</title><author><name sortKey="Arnhold, S" sort="Arnhold, S" uniqKey="Arnhold S" first="S." last="Arnhold">S. Arnhold</name><affiliation><mods:affiliation>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</mods:affiliation></affiliation></author><author><name sortKey="Klein, H" sort="Klein, H" uniqKey="Klein H" first="H." last="Klein">H. Klein</name><affiliation><mods:affiliation>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</mods:affiliation></affiliation></author><author><name sortKey="Benmime, L" sort="Benmime, L" uniqKey="Benmime L" first="L." last="Benmime">L. Benmime</name><affiliation><mods:affiliation>Clinic for Cardiosurgery, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</mods:affiliation></affiliation></author><author><name sortKey="Addicks, K" sort="Addicks, K" uniqKey="Addicks K" first="K." last="Addicks">K. Addicks</name><affiliation><mods:affiliation>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Anatomia, Histologia, Embryologia</title><idno type="ISSN">0340-2096</idno><idno type="eISSN">1439-0264</idno><imprint><publisher>Blackwell Verlag GmbH</publisher><pubPlace>Berlin, Germany</pubPlace><date type="published" when="2005-12">2005-12</date><biblScope unit="volume">34</biblScope><biblScope unit="supplement">s1</biblScope><biblScope unit="page" from="4">4</biblScope><biblScope unit="page" to="5">5</biblScope></imprint><idno type="ISSN">0340-2096</idno></series><idno type="istex">9FA51D35AF5B7CF622B27D12E76A80A775E80781</idno><idno type="DOI">10.1111/j.1439-0264.2005.00669_10.x</idno><idno type="ArticleID">AHE669_10_10</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0340-2096</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Bone marrow derived stromal cells are of mesenchymal origin and precursor cells for skeletal tissue components such as chondroblasts and osteoblasts. Furthermore, under experimental conditions, a differentiation potency into myogenic and neuronal cells could be demonstrated. Because of their multipotency these cells represent a population of non‐haematogen stem cells that can be regarded as an alternative to human embryonic stem cells for future autologous cell replacement therapies. For a closer look at the differentiation capacity of these cells, rat and human bone marrow stromal cells were isolated from the femur bone and kept in the cell culture applying different cultivation protocols. In a cultivation medium with a serum content of 20%, the majority of these cells express a variety of neuronal markers such as ß‐III Tubulin and NeuN as well as the astrocyte marker GFAP, while a minority of about 20% express the marker for neural precursor cells nestin. Cultivation in a chemically defined serum free medium results in the differentiation of a markedly higher percentage of nestin positive neural precursor‐like cells. Using bFGF in combination with B27 these cells can be forced to form three dimensionally organized spheres. In order to elucidate a possible therapeutical potency of the bone marrow derived cells the synthesis of neurotrophic factors such as BDNF and NGF were analysed using the ELISA technique. Furthermore, they can be infected using a third generation adenoviral vector with high efficiency and show migratory activity in vitro. After injection of bone marrow derived mesenchymal stem cells into the lateral ventricle of adult rats they adhere to the ependymocytes and pass the ependymal barrier in order to settle in the subventricular space.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>S. Arnhold</name><affiliations><json:string>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</json:string></affiliations></json:item><json:item><name>H. Klein</name><affiliations><json:string>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</json:string></affiliations></json:item><json:item><name>L. BenMime</name><affiliations><json:string>Clinic for Cardiosurgery, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</json:string></affiliations></json:item><json:item><name>K. Addicks</name><affiliations><json:string>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</json:string></affiliations></json:item></author><articleId><json:string>AHE669_10_10</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>abstract</json:string></originalGenre><abstract>Bone marrow derived stromal cells are of mesenchymal origin and precursor cells for skeletal tissue components such as chondroblasts and osteoblasts. Furthermore, under experimental conditions, a differentiation potency into myogenic and neuronal cells could be demonstrated. Because of their multipotency these cells represent a population of non‐haematogen stem cells that can be regarded as an alternative to human embryonic stem cells for future autologous cell replacement therapies. For a closer look at the differentiation capacity of these cells, rat and human bone marrow stromal cells were isolated from the femur bone and kept in the cell culture applying different cultivation protocols. In a cultivation medium with a serum content of 20%, the majority of these cells express a variety of neuronal markers such as ß‐III Tubulin and NeuN as well as the astrocyte marker GFAP, while a minority of about 20% express the marker for neural precursor cells nestin. Cultivation in a chemically defined serum free medium results in the differentiation of a markedly higher percentage of nestin positive neural precursor‐like cells. Using bFGF in combination with B27 these cells can be forced to form three dimensionally organized spheres. In order to elucidate a possible therapeutical potency of the bone marrow derived cells the synthesis of neurotrophic factors such as BDNF and NGF were analysed using the ELISA technique. Furthermore, they can be infected using a third generation adenoviral vector with high efficiency and show migratory activity in vitro. After injection of bone marrow derived mesenchymal stem cells into the lateral ventricle of adult rats they adhere to the ependymocytes and pass the ependymal barrier in order to settle in the subventricular space.</abstract><qualityIndicators><score>8.5</score><pdfVersion>1.4</pdfVersion><pdfPageSize>595 x 842 pts (A4)</pdfPageSize><refBibsNative>false</refBibsNative><abstractCharCount>1783</abstractCharCount><pdfWordCount>39539</pdfWordCount><pdfCharCount>256516</pdfCharCount><pdfPageCount>59</pdfPageCount><abstractWordCount>273</abstractWordCount></qualityIndicators><title>Bone Marrow Mesenchymal Stem Cells: From Characterization of Neural Differentiation to a Possible Therapeutic Use in Neurodegeneration</title><genre><json:string>abstract</json:string></genre><host><volume>34</volume><publisherId><json:string>AHE</json:string></publisherId><pages><last>5</last><first>4</first></pages><issn><json:string>0340-2096</json:string></issn><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1439-0264</json:string></eissn><title>Anatomia, Histologia, Embryologia</title><doi><json:string>10.1111/(ISSN)1439-0264</json:string></doi></host><categories><wos><json:string>science</json:string><json:string>veterinary sciences</json:string><json:string>anatomy & morphology</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>biomedical research</json:string><json:string>developmental biology</json:string></scienceMetrix></categories><publicationDate>2005</publicationDate><copyrightDate>2005</copyrightDate><doi><json:string>10.1111/j.1439-0264.2005.00669_10.x</json:string></doi><id>9FA51D35AF5B7CF622B27D12E76A80A775E80781</id><score>0.024629153</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/9FA51D35AF5B7CF622B27D12E76A80A775E80781/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/9FA51D35AF5B7CF622B27D12E76A80A775E80781/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/9FA51D35AF5B7CF622B27D12E76A80A775E80781/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Bone Marrow Mesenchymal Stem Cells: From Characterization of Neural Differentiation to a Possible Therapeutic Use in Neurodegeneration</title><respStmt><resp>Références bibliographiques récupérées via GROBID</resp><name resp="ISTEX-API">ISTEX-API (INIST-CNRS)</name></respStmt><respStmt><resp>Références bibliographiques récupérées via GROBID</resp><name resp="ISTEX-API">ISTEX-API (INIST-CNRS)</name></respStmt></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Verlag GmbH</publisher><pubPlace>Berlin, Germany</pubPlace><availability><p>WILEY</p></availability><date>2005</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Bone Marrow Mesenchymal Stem Cells: From Characterization of Neural Differentiation to a Possible Therapeutic Use in Neurodegeneration</title><author xml:id="author-1"><persName><forename type="first">S.</forename><surname>Arnhold</surname></persName><affiliation>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</affiliation></author><author xml:id="author-2"><persName><forename type="first">H.</forename><surname>Klein</surname></persName><affiliation>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</affiliation></author><author xml:id="author-3"><persName><forename type="first">L.</forename><surname>BenMime</surname></persName><affiliation>Clinic for Cardiosurgery, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</affiliation></author><author xml:id="author-4"><persName><forename type="first">K.</forename><surname>Addicks</surname></persName><affiliation>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</affiliation></author></analytic><monogr><title level="j">Anatomia, Histologia, Embryologia</title><idno type="pISSN">0340-2096</idno><idno type="eISSN">1439-0264</idno><idno type="DOI">10.1111/(ISSN)1439-0264</idno><imprint><publisher>Blackwell Verlag GmbH</publisher><pubPlace>Berlin, Germany</pubPlace><date type="published" when="2005-12"></date><biblScope unit="volume">34</biblScope><biblScope unit="supplement">s1</biblScope><biblScope unit="page" from="4">4</biblScope><biblScope unit="page" to="5">5</biblScope></imprint></monogr><idno type="istex">9FA51D35AF5B7CF622B27D12E76A80A775E80781</idno><idno type="DOI">10.1111/j.1439-0264.2005.00669_10.x</idno><idno type="ArticleID">AHE669_10_10</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2005</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Bone marrow derived stromal cells are of mesenchymal origin and precursor cells for skeletal tissue components such as chondroblasts and osteoblasts. Furthermore, under experimental conditions, a differentiation potency into myogenic and neuronal cells could be demonstrated. Because of their multipotency these cells represent a population of non‐haematogen stem cells that can be regarded as an alternative to human embryonic stem cells for future autologous cell replacement therapies. For a closer look at the differentiation capacity of these cells, rat and human bone marrow stromal cells were isolated from the femur bone and kept in the cell culture applying different cultivation protocols. In a cultivation medium with a serum content of 20%, the majority of these cells express a variety of neuronal markers such as ß‐III Tubulin and NeuN as well as the astrocyte marker GFAP, while a minority of about 20% express the marker for neural precursor cells nestin. Cultivation in a chemically defined serum free medium results in the differentiation of a markedly higher percentage of nestin positive neural precursor‐like cells. Using bFGF in combination with B27 these cells can be forced to form three dimensionally organized spheres. In order to elucidate a possible therapeutical potency of the bone marrow derived cells the synthesis of neurotrophic factors such as BDNF and NGF were analysed using the ELISA technique. Furthermore, they can be infected using a third generation adenoviral vector with high efficiency and show migratory activity in vitro. After injection of bone marrow derived mesenchymal stem cells into the lateral ventricle of adult rats they adhere to the ependymocytes and pass the ependymal barrier in order to settle in the subventricular space.</p></abstract></profileDesc><revisionDesc><change when="2005-12">Published</change><change xml:id="refBibs-istex" who="#ISTEX-API" when="2016-12-13">References added</change><change xml:id="refBibs-istex" who="#ISTEX-API" when="2017-02-8">References added</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/9FA51D35AF5B7CF622B27D12E76A80A775E80781/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley component found"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Verlag GmbH</publisherName><publisherLoc>Berlin, Germany</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1439-0264</doi><issn type="print">0340-2096</issn><issn type="electronic">1439-0264</issn><idGroup><id type="product" value="AHE"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="ANATOMIA HISTOLOGIA EMBRYOLOGIA">Anatomia, Histologia, Embryologia</title></titleGroup></publicationMeta><publicationMeta level="part" position="12000"><doi origin="wiley">10.1111/ahe.2005.34.issue-s1</doi><numberingGroup><numbering type="journalVolume" number="34">34</numbering><numbering type="supplement">s1</numbering></numberingGroup><coverDate startDate="2005-12">December 2005</coverDate></publicationMeta><publicationMeta level="unit" type="abstract" position="1" status="forIssue"><doi origin="wiley">10.1111/j.1439-0264.2005.00669_10.x</doi><idGroup><id type="unit" value="AHE669_10_10"></id></idGroup><titleGroup><title type="tocHeading1">Abstracts of the XXVth Congress of the European Association of Veterinary Anatomists (EAVA), Oslo, 28–31 July 2004</title></titleGroup><eventGroup><event type="firstOnline" date="2005-11-22"></event><event type="publishedOnlineFinalForm" date="2005-11-22"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.6 mode:FullText source:Header result:Header" date="2010-04-14"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-01"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-14"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="4">4</numbering><numbering type="pageLast" number="5">5</numbering></numberingGroup><linkGroup><link type="toTypesetVersion" href="file:AHE.AHE669_10_10.pdf"></link></linkGroup></publicationMeta><contentMeta><titleGroup><title type="main">Bone Marrow Mesenchymal Stem Cells: From Characterization of Neural Differentiation to a Possible Therapeutic Use in Neurodegeneration</title><title type="short">Abstracts</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a10-1"><personName><givenNames>S.</givenNames><familyName>Arnhold</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a10-1"><personName><givenNames>H.</givenNames><familyName>Klein</familyName></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#a10-2"><personName><givenNames>L.</givenNames><familyName>BenMime</familyName></personName></creator><creator creatorRole="author" xml:id="cr4" affiliationRef="#a10-1"><personName><givenNames>K.</givenNames><familyName>Addicks</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a10-1" countryCode="DE"><unparsedAffiliation>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</unparsedAffiliation></affiliation><affiliation xml:id="a10-2" countryCode="DE"><unparsedAffiliation>Clinic for Cardiosurgery, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</unparsedAffiliation></affiliation></affiliationGroup><abstractGroup><abstract type="main" xml:lang="en"><p>Bone marrow derived stromal cells are of mesenchymal origin and precursor cells for skeletal tissue components such as chondroblasts and osteoblasts. Furthermore, under experimental conditions, a differentiation potency into myogenic and neuronal cells could be demonstrated. Because of their multipotency these cells represent a population of non‐haematogen stem cells that can be regarded as an alternative to human embryonic stem cells for future autologous cell replacement therapies. For a closer look at the differentiation capacity of these cells, rat and human bone marrow stromal cells were isolated from the femur bone and kept in the cell culture applying different cultivation protocols. In a cultivation medium with a serum content of 20%, the majority of these cells express a variety of neuronal markers such as ß‐III Tubulin and NeuN as well as the astrocyte marker GFAP, while a minority of about 20% express the marker for neural precursor cells nestin. Cultivation in a chemically defined serum free medium results in the differentiation of a markedly higher percentage of nestin positive neural precursor‐like cells. Using bFGF in combination with B27 these cells can be forced to form three dimensionally organized spheres. In order to elucidate a possible therapeutical potency of the bone marrow derived cells the synthesis of neurotrophic factors such as BDNF and NGF were analysed using the ELISA technique. Furthermore, they can be infected using a third generation adenoviral vector with high efficiency and show migratory activity <i>in vitro</i>. After injection of bone marrow derived mesenchymal stem cells into the lateral ventricle of adult rats they adhere to the ependymocytes and pass the ependymal barrier in order to settle in the subventricular space.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Bone Marrow Mesenchymal Stem Cells: From Characterization of Neural Differentiation to a Possible Therapeutic Use in Neurodegeneration</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Abstracts</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Bone Marrow Mesenchymal Stem Cells: From Characterization of Neural Differentiation to a Possible Therapeutic Use in Neurodegeneration</title></titleInfo><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Arnhold</namePart><affiliation>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.</namePart><namePart type="family">Klein</namePart><affiliation>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">BenMime</namePart><affiliation>Clinic for Cardiosurgery, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Addicks</namePart><affiliation>Department of Anatomy I, University of Cologne, J.‐Stelzmanstrasse 9, 50931 Köln, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="abstract" displayLabel="abstract"></genre><originInfo><publisher>Blackwell Verlag GmbH</publisher><place><placeTerm type="text">Berlin, Germany</placeTerm></place><dateIssued encoding="w3cdtf">2005-12</dateIssued><copyrightDate encoding="w3cdtf">2005</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">Bone marrow derived stromal cells are of mesenchymal origin and precursor cells for skeletal tissue components such as chondroblasts and osteoblasts. Furthermore, under experimental conditions, a differentiation potency into myogenic and neuronal cells could be demonstrated. Because of their multipotency these cells represent a population of non‐haematogen stem cells that can be regarded as an alternative to human embryonic stem cells for future autologous cell replacement therapies. For a closer look at the differentiation capacity of these cells, rat and human bone marrow stromal cells were isolated from the femur bone and kept in the cell culture applying different cultivation protocols. In a cultivation medium with a serum content of 20%, the majority of these cells express a variety of neuronal markers such as ß‐III Tubulin and NeuN as well as the astrocyte marker GFAP, while a minority of about 20% express the marker for neural precursor cells nestin. Cultivation in a chemically defined serum free medium results in the differentiation of a markedly higher percentage of nestin positive neural precursor‐like cells. Using bFGF in combination with B27 these cells can be forced to form three dimensionally organized spheres. In order to elucidate a possible therapeutical potency of the bone marrow derived cells the synthesis of neurotrophic factors such as BDNF and NGF were analysed using the ELISA technique. Furthermore, they can be infected using a third generation adenoviral vector with high efficiency and show migratory activity in vitro. After injection of bone marrow derived mesenchymal stem cells into the lateral ventricle of adult rats they adhere to the ependymocytes and pass the ependymal barrier in order to settle in the subventricular space.</abstract><relatedItem type="host"><titleInfo><title>Anatomia, Histologia, Embryologia</title></titleInfo><genre type="journal">journal</genre><identifier type="ISSN">0340-2096</identifier><identifier type="eISSN">1439-0264</identifier><identifier type="DOI">10.1111/(ISSN)1439-0264</identifier><identifier type="PublisherID">AHE</identifier><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><detail type="supplement"><caption>Suppl. no.</caption><number>s1</number></detail><extent unit="pages"><start>4</start><end>5</end></extent></part></relatedItem><identifier type="istex">9FA51D35AF5B7CF622B27D12E76A80A775E80781</identifier><identifier type="DOI">10.1111/j.1439-0264.2005.00669_10.x</identifier><identifier type="ArticleID">AHE669_10_10</identifier><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Verlag GmbH</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Eau/explor/EsturgeonV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001619 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001619 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Eau
|area= EsturgeonV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:9FA51D35AF5B7CF622B27D12E76A80A775E80781
|texte= Bone Marrow Mesenchymal Stem Cells: From Characterization of Neural Differentiation to a Possible Therapeutic Use in Neurodegeneration
}}
| This area was generated with Dilib version V0.6.27. |  |